Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Strassmaier

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Toxicology and Applied Pharmacology|March 27, 2020
A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigmBradley J Ridder, Derek J Leishman, Matthew Bridgland-Taylor, et al.
Toxicology and Applied Pharmacology|April 6, 2020
Corrigendum to "A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm" [Toxicology and Applied Pharmacology volume 394C (2020) 114961]Bradley J Ridder, Derek J Leishman, Matthew Bridgland-Taylor, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Toxicology and Applied Pharmacology|March 27, 2020
A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigmBradley J Ridder, Derek J Leishman, Matthew Bridgland-Taylor, et al.
Toxicology and Applied Pharmacology|April 6, 2020
Corrigendum to "A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm" [Toxicology and Applied Pharmacology volume 394C (2020) 114961]Bradley J Ridder, Derek J Leishman, Matthew Bridgland-Taylor, et al.
Pageof 2